Home › Funds › Rangeley Capital, LLC › PRTA

Rangeley Capital, LLC position in PRTA

PROTHENA CORP PLC · Health Care

Rangeley Capital, LLC reported holding 417,270 shares of PRTA (PROTHENA CORP PLC) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 3.89% of its reported portfolio and ranking #3 among its reported holdings. Rangeley Capital, LLC has disclosed PRTA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)417.27K sh
Reported value held$4.09M
Portfolio Weight3.89%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rangeley Capital, LLC's PRTA position evolved

Rangeley Capital, LLC first disclosed a stake in PRTA in Q2 2025 at 715,367 shares (US$4.3M). The position peaked in Q3 2025 at 560,457 shares, worth US$5.5M. Across 5 filings, Rangeley Capital, LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 417,270 shares valued at US$4.1M — a reduction of -32,190 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 715.37K $4.34M New
Q3 2025 560.46K $5.47M Reduce
Q4 2025 524.60K $5.01M Reduce
Q1 2026 449.46K $4.37M Reduce
Q2 2026 417.27K $4.09M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRTA and 13F data

PRTA (PROTHENA CORP PLC) is a Health Care company. 21 other funds we track also report a position in PRTA — the largest reported positions include ADAR1 Capital Management, LLC (US$15.2M), Palo Alto Investors LP (US$11.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRTA

All PRTA fund holders →

FAQ

How long has Rangeley Capital, LLC held PRTA?

Rangeley Capital, LLC has disclosed PRTA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Rangeley Capital, LLC's current position in PRTA?

As of Q2 2026, Rangeley Capital, LLC holds 417.27K shares of PRTA (PROTHENA CORP PLC), valued at $4.09M, representing 3.89% of its reported portfolio and ranking #3.

Has Rangeley Capital, LLC been buying or selling PRTA?

In the latest 13F filing (Q2 2026), Rangeley Capital, LLC reduced its position in PRTA. The position peaked in Q3 2025 at 560.46K shares.

Which other funds hold PRTA?

Other major institutional holders of PRTA include ADAR1 Capital Management, LLC, Palo Alto Investors LP, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.